| Home
> Table of Contents
> Case Reports |
| |
| Intraocular Malignancy - Uveal
Melanoma |
| |
| Hemkala L Trivedi*, Vivek Arbhave**,
Sujit Murade**, Hemant Todkar**, Rupali Sinha**, Sunil Chawan** |
| |
A 70 year male patient presented
with gradual loss of vision and axial proptosis of right eye
over a period of 6 months.
On examination the vision in right eye was found with
no perception of light in all the quadrants. On slit lamp examination
the right eye showed distorted and oedematous upper lid with
chemosis of bulbar conjunctiva. Cornea showed exposure keratitis.
Extraocular movements of right eye were absent. On direct and
indirect ophthalmoscopy posterior segment details of right eye
were not visible. On investigation the lesion was found to be
uveal tract malignant melanoma of right eye with extraorbital
extension. The patient was advised right eye exenteration with
skin graft. |
| |
| Introduction |
A choroidol melanoma is a malignant tumour
composed of melanocytes pigment containing and producing
cells, normally present in the choroid. It is the most
common intraocular malignancy in adults. The incidence
of melanoma is highest from ages 50-70 and is same in
men and women. Very few cases occur in people under 30
years of age. The cause of choroidal melanoma is unknown.
Inheritance seems to be of little importance. There is
some evidence that environmental factors (carcinogens
such as cigarette smoke) may play a role. Choroidal melanomas
may produce no symptoms initially if located away from
macula.
A tumour that develop next to or in the macula may produce
distorted or reduced vision. Tumours located away from
the macula may produce changes in the visual field and
patient may develop changes in the vitreous and produce
flashes of light or floaters. Retinal detachment, glaucoma
and rarely pigmentation of sclera are some of the manifestations
of the choroidal melanoma.
|
| |
| Case Report |
A 70 years male patient came in the out patient department
of ophthalmology in Nair hospital with gradual loss of
vision and axial proptosis of right eye over a period
of 6 months (Fig. 1). Patient had history of cigarette
smoking for 50 years. On examination the vision in right
eye was found with no perception of light in all the quadrants.
Extraocular movements of right eye were absent. Right
eye upper lid was oedematous and distorted with bulbar
conjunctiva showing chemosis . Cornea of right eye showed
features of exposure keratitis. Exophthalmometry with
Hertels exophthalmometry showed axial proptosis of 36
mm and left eye 20 mm from lateral orbital margin. The
right eye showed black mass involving entire eye behind
the equator. On direct and indirect ophthalmoscopy the
posterior segment details were not visible. The examination
of left eye revealed that it was absolutely normal.
On USG-B-scan of right eye showed a dome shaped mass
involving uveal tract and the entire posterior segment
along with the optic nerve infiltration. The mass had
reflectivity and cascading effect and measured about 10.6
X 8.6 mm in size. It also showed inferior exudative retinal
detachment of right eye.
 |
Fig. 1 : Axial proptosis Rt eye. |
On CT scan with orbital and brain cuts of right eye showed
dome shaped mass involving entire eye upto equator, erosions
of medial wall and floor of the orbit (Fig. 2).
The lateral wall of right eye showed black pigmentation.
Infiltration of the extraocular muscle was also evident.
Infiltration of the optic nerve except posterior part
of optic nerve near the canal was evident.
Blood investigations, USG abdomen, X-ray chest PA view
were normal. The Exenterated mass measured about 8 mm
X 10 mm (Fig. 3).
The exenterated mass was sent for histological examination
which showed large oval round epithelial cells with well-demarcated
cell membranes, eosinophilic cytoplasm and round nuclei
with prominent nucleoli. The patient was followed up for
about 8 months after surgery and was found to have no
metastatic involvement of other organs. Patient later
didn’t followed up. The relative of the patient
reported after about one year that the patient died due
to Juandice in village. |
| |
| Discussion |
Choroidol melanoma constitutes 80% of all the intraocular
tumours. The incidence is highest in the age group of
50-70 age. The sex ratio is equal for both men and women.
Very few cases are recorded below 30 years of age. The
cause of choroidal melanoma is unknown. Inheritance seems
to be of very little importance. Environmental factors
such as cigarette smoke may play a role by influencing
benign pigmented cells to change into malignant cells.
The white population are more affected than black. Choroidal
melanomas are very uncommon in Indian population. Diagnosis
can be made clinically, aided by radiological and blood
investigations. The blood investigation included liver
function test which can reveal metastatic changes in liver.
In radiological methods. B-scan, aided with A-mode can
reveal the size, shape excavation and shadowing in the
orbit. CT-scan and MRI are used to rule out extraocular
metastasis.
 |
Fig. 3 : The operated mass measured 8 mm x 10 mm. |
Fluorescence angiography is used to detect extensive
leakage with progressive fluorescence, late staining of
the lesion. X-ray chest and mammography are also used
to detect metastasis. Indocyanine green angiography, colour-coded
doppler and fine needle aspiration biopsy are also used
in diagnosis. Positron emission tomography, 31P magnetic
resonance spectroscopy and monoclonal antibody tagged
with a short lived radioactive technetium 99m tracer are
new modalities of investigation. Mortality of the patients
depends upon the types of cells the tumour has. |
| |
| Modalities of Treatment Enucleation |
| he patient having large tumours more than
100 mm2 and when the vision is irreversibly lost, the choice
of treatment is enucleation. Enucleation is performed with
gentle isolation and section of the extraocular muscles
and minimal traction on the optic nerve when cutting.8 After
7 weeks patient can be fitted with an artificial eye. |
| |
| Trans-scleral Local Resection |
| Patients having tumours less than 16 mm in diameter are
usually selected for trans-scleral local resection. The
procedure involves excision of the tumours with a rim of
healthy choroid under a partial thickness scleral flap.11 |
| |
| Plaque Radiotherapy |
Tumours less than 10 mm in elevation and less than
20 mm in basal diameters are treated with plaque radiotherapy.
The procedure involves outlining the tumour with methylene
blue which is further outlined with diathermy. A transparent
perspex dummy applicator is temporarily centred over the
tumour and pre-placed sutures are inserted.
The dummy applicator is replaced with a radioactive plaque
of same size. 25I is considered ideal for intraocular
tumours. With energy of 0.039 Mev and it lacks alpha or
beta rays.12 Other isotopes used are radon with energy
range of 0.22 to 2.20 Mev and short life of 3.8 days.
And 60Co with energy of 1.77 to 1.33 Mev.6 The disadvantage
of these isotopes is high tissue penetration which may
cause damage to normal tissue. The response of the therapy
can best evaluated by clinical examination, colour photograph
and utlrasonography of the tumour. Tumour regression starts
after 1-2 months of the treatment. |
| |
| Charged Particle Irradiation |
| Tumour of 24 mm in diameter and 14 mm in height and also
posterior location to within 4 mm of disc or fovea are treated
by this therapy. In this therapy four tantalum rings 2.5
mm in diameter are sutured to the sclera to outline tumour.7
Tumours in contact with optic nerve have rings placed at
anterior and lateral margins of tumours. After estimating
the size, shape, location of tumour, protons or helium are
delivered to the eye by means of a cyclotron unit over 4
days with each dose delivered over a 30 sec period. Majority
of patients receives a dose of 70 cobalt Gy.1 Tumour regression
starts after 6 months of treatment. |
| |
| Transpupillary Thermotherapy |
| Small tumours located near the fovea and optic disc are
treated with this therapy. It can also be a complement modality
to brachytherapy. A diode laser is applied for 1 minute
to induce hyperthermia. |
| |
| Laser Photocoagulation |
| Adjunctive therapy for small recurrences after plaque
therapy but has been largely suppressed by transpupillary
thermotherapy.10 |
| |
| Exenteration |
| Indicated for patients with extensive extraocular extension
at the time of diagnosis or for orbital recurrence following
enucleation. |
| |
| Palliation |
| Chemotherapy and immunotherapy may prolong life in patients
with metastatic disease. In patients with lung metastasis,
life expectancy is generally < 1 year and when liver
is involved < 3 months. |
| |
| Conclusion |
| Choroidal tumour form about 80% of all the intraocular
tumours. Incidence is highest between 50-70 age group. Depending
upon the size, location, metastasis the mode of management
is decided. Initially enucleation was considered as an only
treatment. But addition of new modulations like plaque radiotherapy,
charged particle irradiation, transpupillary thermotherapy,
laser photocoagulation the rate of mortality among the patients
has decreased. |
| |
| References |
| 1. |
Char DH, Saunders W, Castro
JR, et al. Helium in therapy for choroidol melanoma
ophthalmology 1983; 90 : 1219-25. |
| 2. |
Char DH, Schwartz A, Miller TR, Abele
JS. Ocular metastases from systemic melanoma. Am J
Ophthalmol 1980; 90 : 702-07. |
| 3. |
Char DH, Stune RD, Irvine AR, et al.
Diagnostic modalities in choroidal melanoma. Am J
Ophthalmol 1980; 89 : 223-30. |
| 4. |
Constable IJ, Kochler AM. Experimental
ocular irradiation with accelerated proton invest.
Ophthalmol 1974; 13 : 280-87. |
| 5. |
Eurle J, Kline RW, Robertson PM. Selection
of iodine 125 for the collaborative ocular melanoma
study. Arch Ophthalmol 1987; 105 : 763-64. |
| 6. |
Finger PT. Microwave Plaque thermoradiotherapy
for choroidal melanomas. Br J Ophthalmol 1992; 76
: 358-64. |
| 7. |
Gragoudas ES, Seldon JM, Egan KM, et
al. Metastasis from uveal melanoma after proton bean
irradiation. Ophthalmology 1988; 95 : 992-99. |
| 8. |
Jakobiee FA. A meratorium on enucleation
for choroidal melanoma. Am J Ophthalmol 1979; 87 :
842-46. |
| 9. |
Margo CE, McLean IW. Malignant melanomas
of the choroid and ciliary body in black patients.
Arch Ophthalmol 1984; 102 : 77-79. |
| 10. |
Meyer Schuviokerath G. Vogel M. Treatment
of malignant melanomas of the choroid by photocoagulation.
Trans Ophthalmol Sol UK 1977; 97 : 416-20. |
| 11. |
Meyer Schwickerath G. Excision of malignant
melanoma of the choroid. Mod Probl Ophthalmol 1974;
12 : 562-6. |
| 12. |
Pocker S, Retman M, Salanitro P. Iodine-125
irradiation of choroidal melanoma : Clinical experience.
Ophthalmology 1984; 91 : 1700-7. |
| 13. |
Pockers S, Stollers S, Lesser ML,
et al. Long term results of iodine 125 irradiation
of uveal melanoma. Ophthalmology 1992; 99 : 767-74.
|
| 14. |
Shields JA. Current approaches to the
diagnosis and management of choroidal melanomas. Surv
Ophthalmol 1977; 21 : 443-63. |
| 15. |
Shields JA. Diagnosis and management
of intraocular tumours St. Louis, CV Mosby, 1983 pp
75-254. |
| |
|
DEMEDICALISING NECK PAIN HELPS PATIENTS
Brief physiotherapy interventions focused on demedicalising the problem and teaching the principles of cognitive behaviour therapy can be as beneficial as standard physiotherapy for patients who prefer this treatment. Klaber Moffett and colleagues randomised 268 patients to standard physiotherapy (five sessions) or up to three sessions of the brief intervention. Overall, patients who received standard care reported a significant improvement compared with patients in the brief intervention group, but patients who preferred the brief intervention and received this treatment had similar outcomes to patients receiving usual physiotherapy.
BMJ, 2005; 330 : 75.
ST JOHN’S WORT IS EFFECTIVE FOR MODERATE TO SEVERE DEPRESSION
Hypericum extracts WS 5570 (St John’s wort) is at least as effective as paroxetine and is better tolerated as a treatment for moderate to severe depression. In a double blind, double dummy, reference controlled, multicentre non-inferiority trials, Szegedi and colleagues randomised 251 adults to 900 mg/day of hypericum extract WS 5570 or to 20 mg/day paroxetine. The decrease in depression score 42 days later was more than 55% for patients taking St John’s wort and less than 45% in the group taking paroxetine.
BMJ, 2005; 330 : 503. |
|
|
|
*Associate Professor; **Post Graduate Resident,
Department of Ophthalmology, TNMC and BYL Nair Hospital, Mumbai 400 008.
|
|
|